Dr Karthik Anantharaman is the Chief Marketing Officer (Vice President Marketing) with BPL Medical Technologies, a Goldman Sachs Portfolio Company from September 2013 until present. Dr Karthik Anantharaman also plays the role of marketing consultant for Penlon Ltd, a UK based world leader in Anesthesia & Operating Room solutions, a company acquired by BPL Medical Technologies in 2015.
Karthik is a trained medical doctor with a degree in Internal Medicine & Surgery (MBBS) from Bangalore University, A post graduate MBA in Marketing from Manipal University & a super specialization MBA- GELP from Yale School of Management, Yale University, New Haven, Connecticut, USA. Karthik is the recipient of Most Influential Marketing Leaders listing by World Marketing Congress twice in a row, in Nov 2015 & in Nov 2016, leading industry awards from Frost & Sullivan, Economic Times (ET) Best Healthcare Brands & Brand Trust Awards 2016.
Karthik is responsible for driving the overall organizational marketing strategies in line with the revenue and market share targets for the company. Key responsibilities include Brand management, Demand Generation, Customer engagement & Customer relationship management, Pricing, Product marketing, Marketing communications, Competitive Intelligence & Strategic Marketing. In addition to his core responsibility of marketing, Karthik additionally handles the Digital Health (mHealth) business of the company in partnership with leading technology companies like Intel Corporation & Tech Mahindra.
Karthik was earlier the Head of Marketing with GE Healthcare for Molecular Imaging & Computed Tomography business and has held senior managerial positions with leading pharmaceutical organizations like AstraZeneca & MSD (Merck & Co, NJ, USA).
Karthik was one of the core team members responsible for the launch of South Asia first patented primary care pharmaceutical brand, Januvia, which later went on to become the largest pharmaceutical launch of South Asia in 2008-09. Karthik has also had a stint as an entrepreneur launching one of India first Chronic Disease Management companies in 2010-11.